Evaluation of the clinical value of bone metabolic parameters for the screening of osseous metastases compared to bone scintigraphy.

BACKGROUND: Bone metastases are common in many types of cancer. As screening methods different imaging modalities are available. A new approach for the screening of osseous metastases represents the measurement of bone metabolic markers.